These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
64 related items for PubMed ID: 9070884
1. The N-terminal region of NS3 serine proteinase of hepatitis C virus is important to maintain its enzymatic integrity. Mori A, Yuasa S, Yamada K, Nagami Y, Miyamura T. Biochem Biophys Res Commun; 1997 Feb 24; 231(3):738-42. PubMed ID: 9070884 [Abstract] [Full Text] [Related]
3. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies. Cicero DO, Barbato G, Koch U, Ingallinella P, Bianchi E, Nardi MC, Steinkühler C, Cortese R, Matassa V, De Francesco R, Pessi A, Bazzo R. J Mol Biol; 1999 Jun 04; 289(2):385-96. PubMed ID: 10366512 [Abstract] [Full Text] [Related]
4. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells. Hamill P, Jean F. Biochemistry; 2005 May 03; 44(17):6586-96. PubMed ID: 15850392 [Abstract] [Full Text] [Related]
7. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping. Landro JA, Raybuck SA, Luong YP, O'Malley ET, Harbeson SL, Morgenstern KA, Rao G, Livingston DJ. Biochemistry; 1997 Aug 05; 36(31):9340-8. PubMed ID: 9235976 [Abstract] [Full Text] [Related]
12. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles. Chen KX, Njoroge FG, Arasappan A, Venkatraman S, Vibulbhan B, Yang W, Parekh TN, Pichardo J, Prongay A, Cheng KC, Butkiewicz N, Yao N, Madison V, Girijavallabhan V. J Med Chem; 2006 Feb 09; 49(3):995-1005. PubMed ID: 16451065 [Abstract] [Full Text] [Related]
18. The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease. Ontoria JM, Di Marco S, Conte I, Di Francesco ME, Gardelli C, Koch U, Matassa VG, Poma M, Steinkühler C, Volpari C, Harper S. J Med Chem; 2004 Dec 16; 47(26):6443-6. PubMed ID: 15588076 [Abstract] [Full Text] [Related]
19. Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure-activity relationship at the C-terminal position. Rancourt J, Cameron DR, Gorys V, Lamarre D, Poirier M, Thibeault D, Llinàs-Brunet M. J Med Chem; 2004 May 06; 47(10):2511-22. PubMed ID: 15115394 [Abstract] [Full Text] [Related]
20. Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variants. Perni RB, Farmer LJ, Cottrell KM, Court JJ, Courtney LF, Deininger DD, Gates CA, Harbeson SL, Kim JL, Lin C, Lin K, Luong YP, Maxwell JP, Murcko MA, Pitlik J, Rao BG, Schairer WC, Tung RD, Van Drie JH, Wilson K, Thomson JA. Bioorg Med Chem Lett; 2004 Apr 19; 14(8):1939-42. PubMed ID: 15050632 [Abstract] [Full Text] [Related] Page: [Next] [New Search]